SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novartis India informs about board meeting outcome

10 May 2024 Evaluate
In continuation to intimation dated March 27, 2024 and pursuant to Regulations 30, 33, 42 and 43 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015, Novartis India has informed that the Board of Directors of the Company at its Meeting held today i.e. May 10, 2024 have approved the following matters: The Board has approved the Audited Financial Statement for the year ended March 31, 2024 and Audited Financial Results for the quarter & year ended March 31, 2024, as recommended by the Audit Committee. The Board has recommended final dividend of Rs 25 per equity share (of the face value of Rs 5 each) for the financial year ended March 31, 2024, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. Accordingly, the said final dividend, if approved by the shareholders, will be paid on or after August 5, 2024. The 76th AGM of the Company will be held on Wednesday, July 31, 2024 at 11:00 AM (IST) through Video Conferencing / Other Audio-Visual Means in compliance with the applicable provisions of the Circulars issued in this regard by Ministry of Corporate Affairs and Securities and Exchange Board of India from time to time. The Register of Members and Share Transfer books shall be closed from Wednesday, July 24, 2024 to Wednesday, July 31, 2024, for determining the eligibility of shareholders for payment of dividend, if approved by the shareholders at the AGM; etc.

The above information is a part of company’s filings submitted to BSE.

Novartis Share Price

1050.70 12.60 (1.21%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 223.40
Adani Enterprises 2539.40
Amrapali Industries 18.69
Rashi Peripheral 500.90
PDS 288.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×